Case File
efta-efta00998200DOJ Data Set 9OtherFrom: "jeffrey E." <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00998200
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "jeffrey E." <[email protected]>
To: Jeffrey Epstein <[email protected]>
Subject:
Date: Wed, 04 Oct 2017 19:09:25 +0000
From: Magnus Resch
Date: September 12, 2017 at 5:53:37 AM EDT
To: Anastasiya Siro
Subject: Re: shares purchase agreement
Hi Anastasiya,
Aquilamus GmbH is shareholder of common stock. It sold shares to Lviv LLC as a direct secondary purchase. This purchase transaction is
exempt from the registration requirements of the US Securities Act of 1933 under the so called '4(1 'A )' resale exemption. Hence, share
certificates, notarization and inclusion in the shareholder dots are not necessary.
We used a simple doc for the share purchase. If we can help to make this purchase clearer to the IRS we are happy to do this. Please let us
know what is needed, considering that we sold secondaries. We can surely provide SHA, etc. if further documentation is needed to proof that
the entity exists.
Thank you, Magnus
please note
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00998200
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.